Filing Details
- Accession Number:
- 0001209191-20-006282
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 16:11:21
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-04 16:11:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1469443 | Arcadia Biosciences Inc. | RKDA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326765 | T Matthew Plavan | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-03 | 700 | $1.72 | 13,700 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2020-02-03 | 76,000 | $0.00 | 76,000 | $4.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 185,450 | 2030-02-03 | No | 4 | A | Direct |
Footnotes
- Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
- The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.
Billionaire Hedge Funds
